News Outlook Therapeutics, Inc.

Equities

OTLK

US69012T3059

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-19 pm EDT			5-day change	1st Jan Change
8.17 ^USD	-1.45%		-6.09%	+3.68%

Apr. 15	Outlook Therapeutics, Inc. announced that it has received $5.000002 million in funding from Syntone Ventures LLC	CI
Apr. 15	Outlook Therapeutics, Inc. announced that it has received $5.000002 million in funding from Syntone Ventures LLC	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Outlook Therapeutics Announces Closing of Private Placement of $5.0 Million	Apr. 16	AQ
Outlook Therapeutics® Announces Closing of Private Placement of $5.0 Million	Apr. 15	AQ
Outlook Therapeutics, Inc. announced that it has received $5.000002 million in funding from Syntone Ventures LLC	Apr. 14	CI
Outlook Therapeutics, Inc. announced that it has received $5.000002 million in funding from Syntone Ventures LLC	Apr. 14	CI
Corporate Presentation: March 2024	Mar. 28	PU
North American Morning Briefing : Stocks Set for -2-	Mar. 28	DJ
Outlook Therapeutics Shares Rise After BTIG Upgrade	Mar. 27	MT
BTIG Upgrades Outlook Therapeutics to Buy From Neutral, Price Target at $50	Mar. 27	MT
Outlook Therapeutics Reports Secondary Share Offering	Mar. 25	MT
Outlook Therapeutics Receives European Union Positive CHMP Opinion for ONS-5010 as a Treatment for Wet AMD	Mar. 25	AQ
Sector Update: Health Care Stocks Ease Late Afternoon	Mar. 22	MT
Sector Update: Health Care Stocks Ease Friday Afternoon	Mar. 22	MT
Sector Update: Health Care Stocks Steady Pre-Bell Friday	Mar. 22	MT
Outlook Therapeutics Gets EMA Panel Positive Opinion for Wet AMD Treatment -- Shares Rise Pre-Bell	Mar. 22	MT
Outlook Therapeutics® Receives European Union Positive CHMP Opinion for ONS-5010 as a Treatment for Wet AMD	Mar. 22	AQ
Outlook Therapeutics Receives European Union Positive CHMP Opinion for ONS-5010 as a Treatment for Wet AMD	Mar. 22	CI
Outlook Therapeutics® Announces Closing of Private Placement of up to $159 Million	Mar. 18	AQ
Outlook Therapeutics, Inc. announced that it has received $59.999961 million in funding from a group of investors	Mar. 17	CI
Outlook Therapeutics Announces Effective Date for 1-for-20 Reverse Stock Split	Mar. 13	AQ
Outlook Therapeutics to Begin Reverse Stock Split for Regaining Nasdaq Compliance	Mar. 12	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Outlook Therapeutics, Inc.

Equities

OTLK

US69012T3059

Summary

Filters